ProteoMediX ^None

ProteoMediX is a company that originated from ETH Zurich and focuses on discovering new biomarkers for early cancer detection and personalized treatment. They have developed a blood test for prostate cancer diagnosis that is more accurate than the current clinical standard. This test reduces the need for unnecessary biopsies, resulting in cost savings for the healthcare system and less discomfort for patients.